Dr. Amina Zoubeidi is the focus of a Nov. 25 article in the Vancouver Coastal Health Research Institute newsletter. Read the full article here (opens in new window).
As reported on October 30 this year, a study lead by Dr. Zoubeidi with a team from the Vancouver Prostate Centre and collaborators at Weill Cornell Medicine was published online on October 26, in AACR's journal Cancer Discovery. This publication, titled "The Master Neural Transcription Factor BRN2 is an Androgen Receptor Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer", reports a new potential target for treating/preventing neuroendocrine differentiation in prostate tumours. This discovery was also published as a Research Highlight in Nature Reviews Urology.